概要

Rapid Determination of the Thermal Nociceptive Threshold in Diabetic Rats

Published: May 17, 2012
doi:

概要

Here, we describe a rapid reliable and simple procedure to determine the lowest temperature at which rats or mice show nocifensive behavior, i.e. the thermal nociceptive threshold (TNT). This method applies a slowly increasing thermal stimulus allowing precise and reproducible estimation of TNTs with minimum, if any, stress to the animals.

Abstract

Painful diabetic neuropathy (PDN) is characterized by hyperalgesia i.e., increased sensitivity to noxious stimulus, and allodynia i.e., hypersensitivity to normally innocuous stimuli1. Hyperalgesia and allodynia have been studied in many different rodent models of diabetes mellitus2. However, as stated by Bölcskei et al, determination of “pain” in animal models is challenging due to its subjective nature3. Moreover, the traditional methods used to determine behavioral responses to noxious thermal stimuli usually lack reproducibility and pharmacological sensitivity3. For instance, by using the hot-plate method of Ankier4, flinch, withdrawal and/or licking of either hind- and/or fore-paws is quantified as reflex latencies at constant high thermal stimuli (52-55 °C). However, animals that are hyperalgesic to thermal stimulus do not reproducibly show differences in reflex latencies using those supra-threshold temperatures3,5. As the recently described method of Bölcskei et al.6, the procedures described here allows for the rapid, sensitive and reproducible determination of thermal nociceptive thresholds (TNTs) in mice and rats. The method uses slowly increasing thermal stimulus applied mostly to the skin of mouse/rat plantar surface. The method is particularly sensitive to study anti-nociception during hyperalgesic states such as PDN. The procedures described bellow are based on the ones published in detail by Almási et al 5 and Bölcskei et al 3. The procedures described here have been approved the Laboratory Animal Care and Use Committee (LACUC), Wright State University.

Protocol

TNTs of mice and rats are determined by using the incremental hot-plate analgesia meter [iHPAM, IITC Inc. Life Science (Woodland Hills, CA)]. The equipment consists of several components: an aluminum plate (10 x 20 cm) with the heating system underneath and a Plexiglas observation chamber above; a heat controlling unit, software for data acquisition (IITC Part # Soft Series 8), a PC (personal computer) and a footswitch for remote start, stop or reset control of the unit. The heating system also allows starting/stopping/resetting of the heating process manually through a keypad in front of the equipment. The iHPAM can be set to various heating rates, standby/cutoff temperatures.

1. Equipment Set-up

  1. Before testing animals, visually inspect the unit to corroborate the chosen heating rates (e.g., 6 °C/min), initial standby and final cut-off temperatures (e.g., 28 °C and 55 °C, respectively).
  2. Verify all connections. To keep electronic copy of the results, the unit must be connected to a computer running Software Series 8. Alternatively, hard copies of the results can be printed out via the serial port of unit.
  3. Test the equipment. Press the footswitch once to make sure the Software Series 8 records the data: initial standby, final cutoff temperatures and time in seconds required to reach the cut-off temperature.
  4. As a further control test, the investigators involved in the experiments may need to experience the device on themselves. Withdrawing the hand from the metal plate at the moment of pain perception (46-48 °C) must neither cause harm to the skin nor produce any later discomfort.
  5. Once the unit has been set and the results from steps 1.3 and 1.4 recorded they can be compared. This is helpful to detect potential problems that could invalidate the use of the unit. For instance, discrepancies between initial standby/final cut-off temperatures and the actual reading of the unit, and/or differences between temperatures displayed by the unit and the actual plate temperature required for hand withdrawal.

2. Testing Normal Animals

Either young or adult Wistar rats [post-natal (p) age 21-25 days], or mice (p21-25) of any genetic background or gender can be used. The mice used in our experiments are of the strain C57BL/6J.

  1. The night before the experiments to be performed, acclimate the animals by placing their cages on the bench where the iHPAM is placed. Two hours before performing the tests, turn on the iHPAM to familiarize the animals with the background noise of the unit. At this point, the iHPAM can be set up and tested to verify proper function (see Steps 1). Food and water is provided ad libitum throughout the test, except when the animal is in the observation chamber (see Step 2.1).
    Note: It is important not to assume that the laboratory conditions in behavioral experiments are controlled by default. Special attention should be paid to genetic and environmental factors that may influence the outcome of the behavioral studies (reviewed in 7).
  2. Gently place a normal mouse/rat in the Plexiglass observation chamber on top of the heating plate of the unit. Allow the animal to acclimate to the warmed surface (set at 28 °C) until the animal shows a comfortable behavior.
    Note: Under this conditions normal adult rats show an initial exploratory behavior, occasionally standing up towards the lid of the observation chamber while sniffing. After a few minutes, rats may show casual bouts of grooming and a relaxed behavior. Sometimes, rats lay with a relaxed body posture (prone extension) while casually sniffing the surroundings. Normal mice are usually more active than rats. However, mice show a relaxed exploratory behavior after few minutes in the observation chamber. It is exceptionally rare to observe either escaping behaviors (e.g., jumping, trying to escape from the observation chamber) or defensive attitudes (e.g., squealing). It is also important to note that mice can communicate pain from one mouse to another8. Therefore, it may be important to test mice placed in separate cages.
  3. Place mirrors in the back of the observation chamber, to permit observations at all angles. A tripod holding a digital video camera may be of help to determine the exact moment at which nocifensive (pain avoiding) behavior had occurred.
  4. Once the animal is comfortable in the observation chamber heat up the plate by pressing the footswitch. When the plate temperature heats up at a rate of 6 °C/minute, normal animals exhibit nocifensive behavior involving either hind-paw* usually temperatures raging from 46 to 48 °C3,5,9,10. Thus, the animal is typical removed form the observation chamber after approximately 3 minutes.
    Note: Observing the typical nocifensive response of a rat or mouse i.e., hind-paw licking, while shaking and/or lifting, is enough to terminate the thermal stimulus. This is achieved by pressing the footswitch. At this moment, the software records the plate’s temperature and the plate immediately cools down until standby temperature (28 °C) is reached (~0.5 min). This temperature i.e., the one that evokes any nocifensive reaction is regarded as the noxious heat threshold (TNT) of the normal (control) animal.
    *Sometimes, particularly in mice, nocifensive behavior to noxious temperature may first be observed in one or both forepaws (e.g., licking while sitting), few seconds before hind-paws. However, fore-paw licking is a normal component of the grooming behavior. Hence, only hind-paw reactions are assessed. In occasions mice may groom their hind-paws as well. However, normal grooming do not last more than a few seconds, does not involve intensive licking and usually ends after cleaning its claws.
  5. Gently remove the animal from the plate and place it in its respective cage. The heat threshold measurement is then repeated for other control (normal) animal.
    Note: TNTs can be determined in a single animal at intervals of 1-2 minutes without removing the animal from the observation chamber. TNT determinations in rats or mice can be repeated several times during several days. This is particularly useful to determine the mean TNT of an individual animal as well as its variation with age.
  6. The TNT of control animals is expressed as the mean of three or more thresholds ± SEM.
  7. Statistical analysis of data obtained is performed to compare different treatment groups of mice or rats. Parametric procedures including Analysis of Variance may be appropriately used where data are normally distributed and where treatment groups are homoskedastic; when these conditions have been satisfied the following approaches can be applied. Analysis of Variance followed by the Newman-Keuls test to detect differences in multiple measurements i.e., repeated individual TNTs with/without treatment or at different time points (e.g., data in Figure 3). The paired Student’s t-test may be used to compare two data groups i.e., TNTs before vs. after drug treatment; the unpaired t-test may be used to determine differences in TNT changes in drug-treated vs. vehicle-treated animals (e.g., data in Figure 4).

3. Testing Diabetic Animals

The streptozotocin (STZ)-induced diabetic rat is the most commonly used animal model to study mechanisms of PDN and to assess analgesic drugs and therapies11,12. Rats made diabetic by a single intraperitoneal dose of STZ (60 mg/kg) can be tested for thermal hyperalgesia during the 3rd week after onset of diabetes11. It is important to note that not all diabetic rats develop PDN. However, animals that do develop hyperalgesia (~50%) can be easily identified. Indeed, their TNTs are lower than normal*.

*To determine TNTs of STZ-diabetic rats, a starting plate temperature of 15 °C instead of 28 °C is used. The reason for these change is that most diabetic animals with PDN are expected to be hyperalgesic2,11. Therefore, they will have lower than normal noxious heat thresholds (e.g., <45 °C).

  1. A diabetic rat is placed in the observation chamber on top of the testing apparatus. The animal is allowed to acclimate to the plate surface until the animal shows a comfortable behavior.
    Note: Typically, a diabetic rat does not show much of the normal behavior. Diabetic rats are usually hypoactive, lethargic; often showing restricted movements and slow grooming. It is rare to observe standings towards the lid of the observation chamber. After few minutes, diabetic rats may calmly stay in a corner of the chamber with casual sniffing of the surroundings.
  2. Once the diabetic animal is comfortable in the observation chamber, the plate is heated up as in Step 2.3 the diabetic rat may exhibit nocifensive behavior involving either hind/fore-paw. This usually happens at non-noxious plate temperatures (e.g., <45 °C), or after no more than 5 minutes in the chamber with the 6 °C/min temperature increase.
    Note: The nocifensive response of a young adult diabetic rat does not differ from that of a normal rat. However, the lowest temperature evoking such behavior is significantly lowered.
  3. See Step 2.4
  4. The mean of more than three thresholds in the day of the experiment expressed as °C ± SEM is considered the noxious heat threshold of the diabetic animal.
    Note: A similar paradigm to the one explained for normal or diabetic rats can be followed to determine the thermal anti-nocifensive effect of analgesics on heat thresholds.

4. Testing Analgesia

The anti-nociceptive properties of drugs (e.g., analgesics) as well as the determination of pharmacologic parameters such as the minimum effective dose can be easily obtained by using the steps explained above. It is predicted that proper doses of an analgesic administered to rats/mice would significantly increase their TNTs. This is particularly sensitive in animals with thermal hyperalgesia3. However, to avoid bias in the interpretation of the results, the investigators involved in the behavioral observation of an animal group must not know or be aware if the animals had been treated or not. Further, drugs to be injected by the observer may be prepared by another investigator and labeled A, B, C, etc. Dosage is provided in a printout, listing individual doses per identified animal.

Depending on the drug being tested, different doses of a potential analgesic may be administered to normal or diabetic animals 5-15 min prior behavioral tests. Proper controls must be included (i.e., age-matched animals injected with vehicle alone and/or diabetic rats without PDN) and tested using identical conditions (e.g., same starting temperature of the plate). Chronic effects of drugs can be tested as well.

5. Representative Results

The lowest plate temperature evoking nocifensive reactions in either hind-paw of young adult normal non-treated rats or mice were determined following steps 2-1 to 2-6. As shown in Figure 1, TNT of normal young adult rats and mice were 47.2 ± 0.2 °C and 47.5 ± 0.5 °C, respectively.

We have observed neither significant daily variation of individual’s TNTs (Figure 2A) nor significant changes of TNTs among individuals of the same age (Figure 2B). TNT differences due to gender were not observed (not shown).

TNTs of young adult STZ-diabetic rats were determined in a similar fashion as for normal rats (Steps 3.1 to 3.3). However, the starting plate’s temperature was set to 15 °C instead of 28 °C. The nocifensive behavior of STZ-diabetic rats was assessed at least three times in an individual and in a daily fashion starting eleven days post-STZ injection. As shown in Figure 3, a significant drop (p<0.01) in the TNT of STZ-diabetic rats becomes evident two weeks post-STZ injection. The mean TNT of STZ-diabetic rats was 45.6 ± 0.1 °C (n=16, pooled values from days 14-23).

Diabetic rats exhibiting significantly lower TNT than normal were considered to have PDN. These rats were used to test the acute anti-nociceptive properties of an analgesic (compound A). TNTs were determined in normal and diabetic rats injected with either a single dose of the compound or vehicle alone five minutes before the test. As shown in Figure 4, a single intra-peritoneal dose of the compound significantly increased TNTs of diabetic rats when compared to rats treated with vehicle alone (45.6 °C vs 47.6 °C, respectively). The anti-nocifensive effect of compound A was also observed in normal rats; although significant (p<0.01), it was less pronounced (47.4 °C vs 48.0 °C, respectively).

Figure 1
Figure 1. Determination of TNTs of normal young adult rats or mice: The TNTs of young adult rats (p21-24) or mice (p20-21) were tested in the iHPAM following the steps outlined above. A total of 12 rats and 25 mice were tested. Measurements were performed during several days and the results were pooled. Results are expressed as mean ± SEM. The minimum and maximum TNT values recorded in these rats were 46.2 °C and 48.6 °C respectively. In the case of mice, the maximum and minimum TNT values recorded were 48.8 °C and 44.9 °C, respectively.

Figure 2
Figure 2. Age-dependency of TNTs in rats and mice: A) Plotted are the TNTs of four normal rats (n=4) of 21 days of age determined at least three times daily during 5 days. B) TNTs of mice littermates determined once at indicated ages. The numbers on top of each determination point represents the number of littermates used.

Figure 3
Figure 3. Diabetic rats become hyperalgesic 3 weeks after the onset of diabetes: TNTs of six (n=6) age matched young adult STZ-diabetic rats were determined every day starting 11 days post-induction of diabetes. Shown are daily TNT averages (mean ± SEM). Diabetic TNTs determined between 11-13 days post-STZ injection were within the normal range (red line). Two weeks after STZ injection TNTs decreased significantly to 45.1 ± 0.4 °C, (p<0.05).

Figure 4
Figure 4. Acute anti-nocifensive effects of compound B in STZ-diabetic rats. Young adult normal rats (blue group n=12) and age matched STZ-diabetic hyperalgesic rats (green group n=6) were tested in the iHPAM after intraperitoneal injection of vehicle (dark bars) or compound A (light bars). The mean TNT ± SEM for each treatment (vehicle control or compound A-treated) are shown. Asterisks denote statistical differences (p<0.05).

Discussion

Similarly to the classic hot plate test to quantify thermal hyperalgesia4,13, the assay of nociception described here permits a fast and reliable way to quantify nocifensive behavior in rats and mice. However, contrary to classic test, the incremental hot-plate method is non-invasive and virtually stress-free. Although some restrain is necessary to perform the test (i.e., the animal must be in the observation chamber), rats or mice are accustomed to similar areas (e.g., housing cages).

Under the conditions described, normal young adult rats and mice showed nocifensive behavior at temperatures surrounding 47 °C. Although these thresholds are slightly higher than those reported by other investigators3,5,13, our results are in agreement with the thermal nociceptive threshold of 46-48 °C observed in humans14, monkeys15 and other animal models10. The differences in TNTs from our studies and those published3,5,13 may be related to the age of the animals used. Indeed, thermal nociceptive thresholds are higher in young adult rats than those of rats that are 4 wk of age or older16.

In conclusion, following the steps outlined above, the incremental hot-plate analgesia meter allows determination of the thermo-nociceptive thresholds of normal/diabetic rats or mice in a reproducible manner. Further, upon administration of analgesics, particularly to hyperalgesic rats, an increase in the TNT can be statistically detected. This method can be useful to screen potential analgesics in mice and rats under conditions of minimal stress.

開示

The authors have nothing to disclose.

Acknowledgements

This work was funded by the American Diabetes Association (ADA), Grant JF1-10-14 (MDiF). We would like to thank the personnel of the Laboratory of Animal Resources at WSU. Authors gratefully acknowledge assistance with the statistical analysis of data from Neil Paton, Ph.D.

Materials

Name Company Catalogue number
Incremental Hot-Plate Analgesia Meter IITC Inc. Life Science Part #PE34
Soft Series 8 IITC Inc. Life Science Part # Series8
Streptozotocin Calbiochem 572201

参考文献

  1. Baron, R. Peripheral neuropathic pain: From mechanisms to symptoms. Clin. J. Pain. 16, S12-S20 (2000).
  2. Calcutt, N. A., Jorge, M. C., Yaksh, T. L., Chaplan, S. R. Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: Effects of insulin, aldose reductase inhibition and lidocaine. Pain. 68, 293-299 (1996).
  3. Bolcskei, K., Petho, G., Szolcsanyi, J. Noxious heat threshold measured with slowly increasing temperatures: Novel rat thermal hyperalgesia models. Methods Mol. Biol. 617, 57-66 (2010).
  4. Ankier, S. I. New hot plate tests to quantify antinociceptive and narcotic antagonist activities. Eur. J. Pharmacol. 27, 1-4 (1974).
  5. Almasi, R., Petho, G., Bolcskei, K., Szolcsanyi, J. Effect of resiniferatoxin on the noxious heat threshold temperature in the rat: A novel heat allodynia model sensitive to analgesics. Br. J. Pharmacol. 139, 49-58 (2003).
  6. Bolcskei, K., Horvath, D., Szolcsanyi, J., Petho, G. Heat injury-induced drop of the noxious heat threshold measured with an increasing-temperature water bath: A novel rat thermal hyperalgesia model. Eur. J. Pharmacol. 564, 80-87 (2007).
  7. Chesler, E. J., Wilson, S. G., Lariviere, W. R., Rodriguez-Zas, S. L., Mogil, J. S. Identification and ranking of genetic and laboratory environment factors influencing a behavioral trait, thermal nociception, via computational analysis of a large data archive. Neurosci. Biobehav. Rev. 26, 907-923 (2002).
  8. Langford, D. J., Crager, S. E., Shehzad, Z., Smith, S. B., Sotocinal, S. G., Levenstadt, J. S., Chanda, M. L., Levitin, D. J., Mogil, J. S. Social modulation of pain as evidence for empathy in mice. Science. 312, 1967-1970 (2006).
  9. Hunt, S. P., Koltzenburg, M. . The neurobiology of pain. , (2005).
  10. Willis, W. D. . The pain system : The neural basis of nociceptive transmission in the mammalian nervous system. , (1985).
  11. Calcutt, N. . Modeling diabetic sensory neuropathy in rats. In: Methods in molecular medicine. Pain research: Methods and protocols. , (2004).
  12. Bars, D. L. e., Gozariu, M., Cadden, S. W. Animal models of nociception. Pharmacol. Rev. 53, 597-652 (2001).
  13. Shaikh, A. S., Somani, R. S. Animal models and biomarkers of neuropathy in diabetic rodents. Indian J. Pharmacol. 42, 129-134 (2010).
  14. Hargreaves, K., Dubner, R., Brown, F., Flores, C., Joris, J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32, 77-88 (1988).
  15. Hardy, J. D. Method for the rapid measurement of skin temperature during exposure to intense thermal radiation. J. Appl. Physiol. 5, 559-566 (1953).
  16. Sumino, R., Dubner, R., Starkman, S. Responses of small myelinated &quot;warm&quot; fibers to noxious heat stimuli applied to the monkey’s face. Brain Res. 62, 260-263 (1973).
  17. Hammond, D. L., Ruda, M. A. Developmental alterations in thermal nociceptive threshold and the distribution of immunoreactive calcitonin gene-related peptide and substance p after neonatal administration of capsaicin in the rat. Neurosci. Lett. 97, 57-62 (1989).

Play Video

記事を引用
Alshahrani, S., Fernandez-Conti, F., Araujo, A., DiFulvio, M. Rapid Determination of the Thermal Nociceptive Threshold in Diabetic Rats. J. Vis. Exp. (63), e3785, doi:10.3791/3785 (2012).

View Video